| Historic (1865-12-01 to
2009-12-20) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
mice
|
1478 |
4752.7 |
  |
| 2 |
peptide
|
985 |
4426.2 |
  |
| 3 |
target
|
739 |
3255.5 |
  |
| 4 |
MHC
|
504 |
3250.5 |
  |
| 5 |
CD8
|
512 |
3203.9 |
  |
| 6 |
lysis
|
394 |
2698.3 |
  |
| 7 |
antigen
|
604 |
2561.3 |
  |
| 8 |
Ag
|
333 |
2319.1 |
  |
| 9 |
NK
|
307 |
2102.6 |
  |
| 10 |
CD8+
|
309 |
2039.9 |
  |
| 11 |
IL-2
|
297 |
1949.6 |
  |
| 12 |
IFN-gamma
|
307 |
1859.2 |
  |
| 13 |
melanoma
|
276 |
1792.9 |
  |
| 14 |
HLA
|
240 |
1671.0 |
  |
| 15 |
CD4
|
249 |
1624.1 |
  |
|
| 10 years (1999-12-23 to
2009-12-20) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
CD8
|
394 |
2260.9 |
  |
| 2 |
mice
|
708 |
2024.7 |
  |
| 3 |
peptide
|
487 |
1968.3 |
  |
| 4 |
MHC
|
225 |
1433.7 |
  |
| 5 |
antigen
|
290 |
1213.9 |
  |
| 6 |
CD4
|
193 |
1155.3 |
  |
| 7 |
IFN-gamma
|
209 |
1141.6 |
  |
| 8 |
Ag
|
144 |
996.8 |
  |
| 9 |
CD8+
|
142 |
915.4 |
  |
| 10 |
NK
|
132 |
869.1 |
  |
| 11 |
target
|
216 |
813.3 |
  |
| 12 |
melanoma
|
136 |
810.6 |
  |
| 13 |
HLA
|
118 |
805.8 |
  |
| 14 |
IL-2
|
113 |
781.3 |
  |
| 15 |
lysis
|
108 |
765.6 |
  |
|
|